FDA Boxed Warning: Clopidogrel (Plavix®) Clinical Alert

Updated:Sep 4,2012
FDA Boxed Warning: Clopidogrel (Plavix®) Clinical Alert
  • Clinical antiplatelet effectiveness is reduced for poor metabolizers of clopidogrel. 
  • Genetic tests are available to identify poor metabolizers.
  • Emerging role of genetic testing in clopidogrel treatment decisions

Read full clinical alert in Circulation

Editorial: Responding to the Clopidogrel Warning by the US Food and Drug Administration: Real Life Is Complicated
by Dan M. Roden, M.D., and Alan R. Shuldiner, M.D.

Supporting Materials

Other AHA Statements on Anticoagulation


Network with over 31,000 Heart and Stroke Professionals

DS-5610 PON Banner 280X137
  • Connect with others around the world
  • Share and discuss articles by prominent heart and stroke researchers
     
    Join the AHA's Professional Online Network at networking.americanheart.org    Login to AHA's Professional Online Network at networking.americanheart.org